BIIB

249.7301.05%
CA

Christopher A. Viehbacher

President, CEO & Director

Mr. Christopher A. Viehbacher, also known as Chris, is Outside Advisor of Cloud Pharmaceuticals, Inc. Mr. Viehbacher is the President, Chief Executive Officer & Director at Biogen Inc. since November 14, 2022. Mr. Viehbacher was President, Chief Executive Officer & Director of Biogen MA Inc. He is Director of Innocoll Holdings plc from July 24, 2017. He is Chairman at Braveheart Bio, Inc. He joined the Innocoll Holdings plc on July 24, 2017. since November 14, 2022. He was an Independent Non-Executive Chairman of the Board of PureTech Health plc. and serves as its Director since 2015 until June 14, 2023. He was Interim Chair of PureTech Health plc from September 07, 2019. He served as Chairman of Vedanta Biosciences, Inc. until 2023. He was Director of Crossover Health Medical Group, APC from December 2016. He joined the Crossover Health Medical Group, APC on December 07, 2016. Mr. Viehbacher co-founded Gurnet Point Capital in 2015. He was Founding Partner of Gurnet Point Capital Limited from October 2021. He focused on Digital Health. He was Managing Partner of Gurnet Point Capital Limited from 2015 to 2022. Mr. Viehbacher has been a strong advocate for the healthcare industry, currently serving on the Board of Trustees for Northeastern University, as Chairman of the Board for each of Clario. Mr. Viehbacher has previously served on the Board of Auregen Biotherapeutics. He is Director of Zikani Therapeutics, Inc. from October 05, 2017. He joined the Zikani Therapeutics, Inc. on October 05, 2017. He was Director of BEFORE Brands, Inc. from March 20, 2017. He joined the BEFORE Brands, Inc. on March 20, 2017. He was Director of Alladapt Immunotherapeutics, Inc. He was Chief Executive Officer of Sanofi-Aventis of Sanofi-Aventis U. S. LLC. He was Executive Chairman of Genzyme Corporation. He was employed at Genzyme Corporation from April 2011 to October 01, 2016. He was Chief Executive Officer and Director of Sanofi. He was employed as Global CEO of Sanofi S.A. from December 01, 2008 to October 29, 2014. He was President of North American Pharmaceuticals of GlaxoSmithKline plc. He was employed at GlaxoSmithKline plc from 1984 to September 08, 2008. He was Director of Corium, Inc. from November 27, 2018 to June 2020. He was employed at Corium, Inc. until June 2020. He was Chief Executive Officer of Sanofi-Aventis S A France of sanofi-aventis Pakistan Limited. He was Chief Executive Officer of Sanofi-Aventis SA. He was Chief Executive Officer of Sanofi-Aventis of BiPar Sciences, Inc. He was Chief Executive Officer of Sanofi-Aventis of Sanofi-Aventis Ireland Ltd. He was Director of Axcella Health Inc. from September 2015 to August 21, 2019. He was employed at Axcella Health Inc. from October 15, 2015 to August 21, 2019. He was Co-Founder & Executive Chairman of Boston Pharmaceuticals Inc. until April 2021. He was Executive Chairman of Boston Pharmaceuticals Inc. He has B. Comm from Queen's University in 1983, Board of Fellows from Stanford Medical School and qualified as a Chartered Accountant.

Positions